American Enterprise Institute scholar, Roger Bate, tested the quality of the antibiotic drug, Ciprofloxacin, purchased in 18 low-to-middle income countries. Of the 1,437 samples tested, more than half were either substandard (9.88%) or counterfeit (41.5%). Counterfeit drugs both failed a visual test and contained no active ingredient. By comparison, substandard drugs are those that passed a visual test but contained less than 80% of the stated active ingredient in lab tests.
American Enterprise Institute scholar, Roger Bate, tested the quality of the antibiotic drug, Ciprofloxacin, purchased in 18 low-to-middle income countries. Of the 1,437 samples tested, more than half were either substandard (9.88%) or counterfeit (41.5%). Counterfeit drugs both failed a visual test and contained no active ingredient. By comparison, substandard drugs are those that passed a visual test but contained less than 80% of the stated active ingredient in lab tests.
Bate’s team found that product registration – that is, registering a drug product with the local government – was associated with higher quality than non-registered drugs. However, a better indicator a drug was not counterfeit was its availability at chain drug stores. In an attempt to maintain a good reputation, chain drug stores policed their suppliers and were better able to keep their inventory free of counterfeits than were local government regulations.
